翰尔西

翰尔西

翰尔西

Biotech/Healthcare

Hanerxi is a developer of pen injectors focused on new drug delivery methods. It has successfully developed China's first adjustable precision-dose injection pen with a complete intellectual property portfolio and has built a technology reserve covering drugs with various physical characteristics.

Latest round: Pre Series A (2021)

Source: ChinaBulls — chinabulls.com

Last updated 2021-02-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.